Cancer
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
10 Oct 2023
Read More
Breath Biopsy
Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer
Read More
7 Feb 2017
Company Updates
Owlstone Medical Announces $11.55M USD Fundraising
Read More
6 Jan 2017
Breath Biopsy
Medtech Insight: “Owlstone Medical is leading the charge on breath analysis”
Read More
11 Dec 2016
Company Updates
Cambridge Business Interview with CEO Billy Boyle
Read More
10 Dec 2016
Breath Biopsy
Owlstone Medical’s ReCIVA Named Invention of the Year in Top 50 Digital Health Awards
Read More
10 Dec 2016
Company Updates
Owlstone Medical Selected to Participate at Upcoming Cavendish Global Health Impact Forum
Read More
5 Dec 2016
Breath Biopsy
Owlstone Medical and Imperial College collaborate to study underlying causes of asthma exacerbations
Read More
1 Nov 2016
Breath Biopsy
Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer
Read More
4 Oct 2016
Breath Biopsy
Owlstone Medical commences next phase in world’s largest breath-based clinical trial for early cancer detection
Read More
22 Sep 2016
Company Updates
Owlstone Medical strengthens management team
Read More
25 Aug 2016
Company Updates
Owlstone Medical tipped as potential ‘Unicorn’ in The Spectator
Read More
8 Aug 2016
Company Updates
Owlstone Medical closes $7M (£4.9M) investment to commercialize disease breathalyzer
Read More
28 Jun 2016

Talk to us about your biomarker research and how Breath Biopsy could help.